These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22766474)

  • 1. Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods.
    Nakamura K; Yamashita K; Itoh Y; Yoshino K; Nozawa S; Kasukawa H
    Biochim Biophys Acta; 2012 Nov; 1818(11):2801-7. PubMed ID: 22766474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of irinotecan-loaded polyethylene glycol-modified liposomes prepared using different PEG-modification methods.
    Yoshino K; Nakamura K; Terajima Y; Kurita A; Matsuzaki T; Yamashita K; Isozaki M; Kasukawa H
    Biochim Biophys Acta; 2012 Nov; 1818(11):2901-7. PubMed ID: 22828450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion stability of poly(ethylene glycol)-cholesteryl-based lipid anchors in liposome membranes.
    Molnar D; Linders J; Mayer C; Schubert R
    Eur J Pharm Biopharm; 2016 Jun; 103():51-61. PubMed ID: 27016212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation.
    Lee CM; Choi Y; Huh EJ; Lee KY; Song HC; Sun MJ; Jeong HJ; Cho CS; Bom HS
    Cancer Biother Radiopharm; 2005 Dec; 20(6):620-8. PubMed ID: 16398614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
    Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
    J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE; Kim IS; Kim CK
    Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.
    Sachse A; Leike JU; Schneider T; Wagner SE; Rössling GL; Krause W; Brandl M
    Invest Radiol; 1997 Jan; 32(1):44-50. PubMed ID: 9007647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.
    Nag OK; Yadav VR; Hedrick A; Awasthi V
    Int J Pharm; 2013 Mar; 446(1-2):119-29. PubMed ID: 23419666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.
    Kim JY; Kim JK; Park JS; Byun Y; Kim CK
    Biomaterials; 2009 Oct; 30(29):5751-6. PubMed ID: 19656559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes.
    Zhao T; Liu Y; Gao Z; Gao D; Li N; Bian Y; Dai K; Liu Z
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():196-203. PubMed ID: 26042707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interfacial cholesterol-anchored polyethylene glycol on sterol-rich non-phospholipid liposomes.
    Cui ZK; Edwards K; Nieto Orellana A; Bastiat G; Benoit JP; Lafleur M
    J Colloid Interface Sci; 2014 Aug; 428():111-20. PubMed ID: 24910042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusogenic activity of PEGylated pH-sensitive liposomes.
    Vanić Z; Barnert S; Süss R; Schubert R
    J Liposome Res; 2012 Jun; 22(2):148-57. PubMed ID: 22149717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
    Laverman P; Brouwers AH; Dams ET; Oyen WJ; Storm G; van Rooijen N; Corstens FH; Boerman OC
    J Pharmacol Exp Ther; 2000 Jun; 293(3):996-1001. PubMed ID: 10869403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.